Related references
Note: Only part of the references are listed.Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU
Christina Creel-Bulos et al.
SHOCK (2021)
Hypercoagulable viscoelastic blood clot characteristics in critically ill coronavirus disease 2019 patients and associations with thrombotic complications
David J. Roh et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2021)
Hemostasis in Coronavirus Disease 2019-Lesson from Viscoelastic Methods: A Systematic Review
Artur Slomka et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Ewan C. Goligher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
COVID-19 Does Not Lead to a Typical Acute Respiratory Distress Syndrome
Luciano Gattinoni et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Dominic Wichmann et al.
ANNALS OF INTERNAL MEDICINE (2020)
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection
Franklin L. Wright et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series
Janice Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A comment
Christopher D. Barrett et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
Mauro Panigada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19
Marisa Dolhnikoff et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Early outcomes with utilization of tissue plasminogen activator in COVID-19-associated respiratory distress: A series of five cases
D. Benjamin Christie et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2020)
Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans
Sharon E. Fox et al.
LANCET RESPIRATORY MEDICINE (2020)
COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis
Hooman D. Poor et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
Hunter B. Moore et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2020)
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
Mouhamed Yazan Abou-Ismail et al.
THROMBOSIS RESEARCH (2020)
Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
Sarah Orfanos et al.
ERJ OPEN RESEARCH (2020)
Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019
Stephanie Hightower et al.
THROMBOSIS RESEARCH (2020)
Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID-19: Study design of the phase IIa STARS trial
Hunter B. Moore et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review
Christopher D. Barrett et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Nonlinear Imputation of PaO2/FIO2 From SpO2/FIO2 Among Patients With Acute Respiratory Distress Syndrome
Samuel M. Brown et al.
CHEST (2016)
Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice
Dena R. Cohen et al.
TRIALS (2015)
Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome
DA Schoenfeld et al.
CRITICAL CARE MEDICINE (2002)
Share Paper
